0001209191-17-032159.txt : 20170512
0001209191-17-032159.hdr.sgml : 20170512
20170512183849
ACCESSION NUMBER: 0001209191-17-032159
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AveXis, Inc.
CENTRAL INDEX KEY: 0001652923
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 901038273
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2275 HALF DAY ROAD
STREET 2: SUITE 160
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
BUSINESS PHONE: 972-725-7797
MAIL ADDRESS:
STREET 1: 2275 HALF DAY ROAD
STREET 2: SUITE 160
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LITALIEN JAMES J
CENTRAL INDEX KEY: 0001182613
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37693
FILM NUMBER: 17840485
MAIL ADDRESS:
STREET 1: C/O SOMAXON PHARMACEUTICALS, INC.
STREET 2: 3721 VALLEY CENTRE DRIVE, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001652923
AveXis, Inc.
AVXS
0001182613
LITALIEN JAMES J
C/O AVEXIS, INC.
2275 HALF DAY ROAD, SUITE 200
BANNOCKBURN
IL
60015
0
1
0
0
SrVP/Chief Reg&Quality Officer
Employee Stock Option (Right to Buy)
77.24
2017-05-10
4
A
0
27827
0.00
A
2027-05-10
Common Stock
27827
27827
D
The option shall vest and become exercisable as to 25% of the shares underlying the option on May 10, 2018; the remaining shares shall vest in 36 equal monthly installments beginning on June 10, 2018, subject to the Reporting Person providing continuous service to the Issuer on each such date.
/s/Madison Jones, Attorney-in-Fact
2017-05-12